House resolution · H.Res. 1285 (119th Congress)

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone…

U.S. House of Representatives

Latest action May 21, 2026

Sponsor: Diana DeGette (U.S. Representative, CO-1, Democratic)

Official titleShow

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

The heading above is this same sentence with its legal opening removed. No words were added, changed or reordered.

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

A non-binding sense-of-the-House resolution. It states the position that the peer-reviewed evidence on the drug mifepristone should be respected, and that laws and policies governing access to medication abortion should be equitable, transparent, and based on peer-reviewed science.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

Introduced
In committee
Up for a vote
Adopted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Cosponsors

Cosponsors listed on Congress.gov, shown A to Z.

Democratic51

Shown in neutral colors by design; Agora is non-partisan.

S.Res. 732A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.Identical bill

As identified by Congress.gov.

Full history

May 21, 2026
Introduced
Introduced in U.S. House
U.S. House
May 14, 2026
In committee
Referred to the House Committee on Energy and Commerce.
U.S. House
May 14, 2026
Referred to committee
Referred to the House Committee on Energy and Commerce.
U.S. House of Representatives
May 14, 2026
Submitted in House
U.S. House of Representatives

Read the record

Read on Congress.gov (opens in a new tab) The official record on Congress.gov.